- Tominaga Y, Fujii M, Sadahira T, Katayama S, Iwata T, Nishimura S, Bekku K, Edamura K, Kobayashi T, Kobayashi Y, Kiura K, Maeda Y, Wada K, Araki M: Bladder tuberculosis with ureteral strictures after bacillus Calmette Guérin therapy for urinary bladder cancer: A case report. Mol Clin Oncol. 2022 Dec 20;18(2):7.
- Watanabe T, Sako T, Tominaga Y, Sadahira T, Sekito T, Takamoto A, Edamura K, Kobayashi Y, Wada K, Araki M: A case of tape infection 19 years after insertion of a tension-free vaginal tape sling. IJU Case Rep. 2022 Mar 28;5(4):228-231.
- Yokoyama S, Tsuboi I, Ogawa K, Yoshioka S, Kobayasi Y, Nakajima H, Nagami T, Yamasaki S, Wada K: Isolated rupture of the corpus spongiosum with urethral injury diagnosed by pre-surgical MRI. IJU Case Rep. 2022 Nov 22;6(1):70-72.
- Tohi Y, Kato T, Fukuhara H, Kobayashi K, Ohira S, Ikeda K, Daizumoto K, Katayama S, Shimizu R, Nishimura K, Nagami T, Hayashida Y, Hirama H, Takamoto A, Dainichi T, Sugimoto M; Chu-shikoku Japan Urological Consortium: Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium. Int J Clin Oncol. 2022 Aug;27(8):1348-1355.
- Sekito T, Araki M, Wada K, Yoshinaga K, Maruyama Y, Sadahira T, Katayama S, Iwata T, Nishimura S, Sako T, Edamura K, Kobayashi Y, Watanabe T: A Novel Technique Using Fluorescent Ureteral Catheter and Flexible Ureteroscope for Safe Laparoscopic Fenestration of Lymphocele after Kidney Transplantation. Case Rep Transplant. 2022 Feb 7;2022:9948425.
- Acosta H, Sadahira T, Sekito T, Maruyama Y, Iwata T, Araki M, Ogawa K, Tsuboi I, Wada K: Post-prostate biopsy acute bacterial prostatitis and screening cultures using selective media: An overview. Int J Urol. 2022 Jun;29(6):486-493.
- Ichihara K, Takahashi S, Hiyama Y, Masumori N, Nagae H, Ito S, Wada K, Betsunoh H, Hamasuna R, Togo Y, Shigemura K, Takeyama K: Distribution of the positive UPOINT domain in patients with chronic prostatitis or chronic pelvic pain syndrome: A multicenter observational study. J Infect Chemother. 2022 May;28(5):631-634.
- Matsuzaki J, Takahashi S, Yamaguchi A, Wada K, Miyazaki J, Mugiya S, Matsuda T, Nutahara K, Seki S, Morimoto T, Yamamoto S: Japanese linguistic validation of the ureteral stent symptom questionnaire. Int J Urol. 2022 Apr;29(4):332-336.
- Tsuboi I, Ogawa K, Wada K: Editorial Comment to Rare case of retropubic parasymphyseal cyst in a male patient. IJU Case Rep. 2021 Oct 26;5(1):40.
- Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Place RF, Pookot D, Majid S, Igawa M, Dahiya R: Retraction Note: Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene. 2022 Nov;41(45):4981.
- Koshiro N, Nakajima K, Oyama M, Kaneko G, Takahashi S, Matsuyama H, Shiina H, Ichikawa T, Horikoshi H, Hashine K, Sugiyama Y, Miyao T, Kamiyama M, Harada K, Ito A, Mizokami A; PROSTAT-BSI Investigators: Predictive factors for the effectiveness of novel androgen receptor axis-targeted agents in patients with metastatic prostate cancer. Int J Urol. 2022 Dec;29(12):1477-1487.
- Yazaki T, Moriyama I, Tobita H, Sonoyama H, Okimoto E, Oka A, Mishima Y, Oshima N, Shibagaki K, Kawashima K, Ishimura N, Nagami T, Maruyama R, Shiina H, Ishihara S: The Simultaneous Onset of Pancreatitis and Colitis as Immune-related Adverse Events in a Patient Receiving Nivolumab Treatment for Renal Cell Carcinoma. Intern Med. 2022 May 15;61(10):1485-1490.
- Kamijima T, Yaegashi H, Mizokami A, Nakajima K, Matsuyama H, Ichikawa T, Nishimoto K, Takahashi S, Shiina H, Horikoshi H, Hashine K, Sugiyama Y, Miyao T, Kamiyama M, Harada K, Ito A, Enokida H: Efficacy of Androgen Receptor-targeted Drugs After Prostate Cancer Recurrence With Bone Metastases: PROSTAT-BSI Sub-analysis. Anticancer Res. 2022 Jun;42(6):3099-3108.
- Mizokami A, Nishimoto K, Matsuyama H, Ichikawa T, Takahashi S, Shiina H, Hashine K, Sugiyama Y, Kamiyama M, Enokida H, Nakajima K: Efficacy of New Therapies for Relapse After Docetaxel Treatment of Bone Metastatic Castration-resistant Prostate Cancer in Clinical Practice. Anticancer Res. 2022 Mar;42(3):1465-1475.
- Nagumo Y, Onozawa M, Kojima T, Terada N, Shiota M, Mitsuzuka K, Yasumoto H, Matsumoto H, Enokida H, Sugiyama T, Kuroiwa K, Saito T, Yokomizo A, Kohei N, Tabata KI, Takahashi A, Sugimoto M, Kitamura H, Kamoto T, Nishiyama H; Japanese Urological Oncology Group (JUOG): Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden. Int J Urol. 2022 May;29(5):398-405.
- Iida K, Miyake M, Murakami K, Komiyama M, Okajima E, Sazuka T, Nishiyama N, Yasumoto H, Kimura T, Ito A, Shiga K, Yamagishi A, Kikuchi H, Sugimoto M, Taoka R, Kobayashi T, Kojima T, Kitamura H, Nishiyama H, Fujimoto K: Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy. Int J Clin Oncol. 2021 Nov;26(11):2104-2112.
- Taoka R, Kobayashi T, Hidaka Y, Abe H, Ito K, Kojima T, Kato M, Kanda S, Hatakeyama S, Matsui Y, Matsushita Y, Naito S, Shiga M, Miyake M, Muro Y, Nakanishi S, Kato Y, Shibuya T, Hayashi T, Yasumoto H, Yoshida T, Uemura M, Kamiyama M, Morita S, Ogawa O, Nishiyama H, Kitamura H, Sugimoto M; Japan Urological Oncology Group: Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma. Urol Oncol. 2022 Mar;40(3):107.e1-107.e9.
- Miyake M, Iida K, Nishimura N, Inoue T, Matsumoto H, Matsuyama H, Fujiwara Y, Komura K, Inamoto T, Azuma H, Yasumoto H, Shiina H, Yonemori M, Enokida H, Nakagawa M, Fukuhara H, Inoue K, Yoshida T, Kinoshita H, Matsuda T, Fujii T, Fujimoto K; Nishinihon Uro-oncology Extensive Collaboration Group: Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy. Eur Urol Open Sci. 2022 May 30;41:95-104.